DarioHealth Corp.

www.dariohealth.com ; shop.mydario.com

Formerly LabStyle Innovations

High-Tech Company
Public Company

(NASDAQ CM: DRIO)

TECH VERTICALS

Artificial Intelligence, B2B2C, Big Data, Data Analytics, Diabetes, Digital Health, Healthtech, IoT, Life Sciences, Machine Learning, Managed Care, Medical Devices, MedTech, Mental Health, Mobile Applications, Quantified Self

General Data

Sector	Digital Health
Company Stage:	Revenue Growth
Established	2010
Number of Employees	260
Employees in Israel	60
Reg. Number:	abCDe

DESCRIPTION

DarioHealth is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario's platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.
Dario's user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.

TECHNOLOGY

Diabetes Management, Hypertension Management, Behavioral Health, Chronic Condition Management, Pain Management, Weight Management.

Products and Phases

Product	Phase
MyDario	FDA Approved CE Approved Health Canada, TGA Australia, WAND New Zealand
The Dario® Blood Glucose Monitoring System is the original, all-in-one smart glucose meter. It syncs with the acclaimed Dario Smart Diabetes Management app to measure, record and track blood glucose levels. In addition, the app records carbs intake, insulin medication, and physical activity.

ESTIMATED ANNUAL SALES

Year	Amount
2023	500
2022	490
2021	480
2020	470
2019	460
2018	450
2017	440

	TARGET MARKETS
	Diabetes patients, Hypertension patients, Individuals with chronic conditions, People coping with weight management, People with musculoskeletal pain, Behavioral health patients, Healthcare providers, Health insurance companies, Corporate wellness programs.

	BUSINESS MODEL
	B2B

REMARKS

Date	Remark
16/08/2020	LabStyle Innovations Ltd. is the Israeli Subsidiary / R&D center of DarioHealth corp.

CONTACT INFO

Expand / Collapse All

Main Address: New York, United States

Address	18 W. 18th St.
City	New York
State/Province	NY
Country	United States
Zip	10011

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Caesarea, Israel - LabStyle Innovations Ltd.

Address	8 Hatokhen St., North Industrial Park
City	Caesarea
Country	Israel
Zip	3088900

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Gurgaon, India

City	Gurgaon
Country	India
Zip	122001

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Erez Raphael	CEO
Mr. Tomer Ben-Kiki	CTO
Dr. Omar Manejwala	Chief Medical Officer
Mr. Zvi Ben-David	CFO	Given Imaging (Corporate VP & CFO)
Ms. Lara Dodo	COO
Ms. Keren Zimmerman	CPO	Oberon Media (VP, Web Search Products & I-play D2C)
Mr. Steven Nelson	Chief Commercial Officer
Ms. Michal Aberman-Shimon	Chief People Officer	Kape (VP, HR)
Ms. Mary Mooney	VP, Marketing
Dr. David Weintraub	Co-Founder
Dr. Oren Fuerst	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Partner, Sequoia Capital
abC Defghij	Board Member	CEO, DarioHealth
abC Defghij	Board Member	Independent Business Consultant
abC Defghij	Board Member	President & CFO, PAVmed Inc.
abC Defghij	Board Member	President & CEO, Sentara Health
abC Defghij	Board Member	CEO, SternAegis Ventures

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Mar. 01, 2022	Third Public Offering	NASDAQ CM	abCDe	abCDe	Registered Direct Offering; Investments from institutional investors, including insurance companies located in Israel and primarily consisting of existing shareholders.
Mar. 07, 2016	Second Public Offering	NASDAQ CM	abCDe	abCDe
Apr. 10, 2013	Listing	OTCQB	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Jan. 21, 2025

Revenue Growth

abCDe

PIPE

Feb. 21, 2024

Revenue Growth

abCDe

PIPE

May. 02, 2023

Revenue Growth

abCDe

Debt Financing

May. 02, 2023

Revenue Growth

abCDe

Debt Financing

Jun. 09, 2022

Revenue Growth

abCDe

PIPE

Jan. 27, 2021

Revenue Growth

abCDe

PIPE

Jul. 31, 2020

Initial Revenues

abCDe

PIPE

Dec. 16, 2019

Initial Revenues

abCDe

PIPE

Sep. 14, 2018

Initial Revenues

abCDe

PIPE

Aug. 23, 2017

Initial Revenues

abCDe

PIPE

Jan. 13, 2017

Revenue Growth

abCDe

PIPE

Aug. 31, 2015

Revenue Growth

abCDe

PIPE

Feb. 25, 2015

Revenue Growth

abCDe

PIPE

Sep. 23, 2014

Revenue Growth

abCDe

PIPE

Feb. 19, 2014

Initial Revenues

abCDe

PIPE

May. 13, 2013

R&D

abCDe

First Round

Nov. 06, 2012

R&D

abCDe

Seed

May. 01, 2010

Seed

abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Jun. 10, 2019

Initial Revenues

Contributor	Type	Amount	Remarks
abC Defghij	Corporate Accelerator	abCDe

	Acquisitions made by Dario

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	Digita...	Feb. 15, 2024	abCDe	$10m upfront cash payment followed by $20m in options to purchase shares of common stock, a payment of $7.5m in common stock to the company's employees and approx. 1.3m shares and options intended for the board of directors (at $2 per share), set to pay out in four tranches at 9 months, 1 year, 18 months, and 2 years post deal closing.
abC Defghij	Digita...	Jan. 19, 2022	abCDe
abC Defghij	Digita...	May. 18, 2021	abCDe
abC Defghij	Digita...	Jan. 27, 2021	abCDe

Last Updated:	abCDe
IVC Number:	abCDe